Apollo Endosurgery (APEN) Reiterates at Buy with $10 Price Target by Stifel, Approved ESG and REVISE are "Next Critical Growth Drivers"
Tweet Send to a Friend
Stifel analyst Mathew Blackman reiterated a Buy rating and $10.00 price target on Apollo Endosurgery (NASDAQ: APEN), following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
